XTX Topco’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100K | Buy |
+34,551
| New | +$100K | ﹤0.01% | 1885 |
|
|
2025
Q1 | – | Sell |
-30,138
| Closed | -$31K | – | 3054 |
|
|
2024
Q4 | $31K | Buy |
+30,138
| New | +$31K | ﹤0.01% | 1964 |
|
|
2024
Q2 | – | Sell |
-15,013
| Closed | -$25.8K | – | 2428 |
|
|
2024
Q1 | $25.8K | Sell |
15,013
-50,953
| -77% | -$87.6K | ﹤0.01% | 1583 |
|
|
2023
Q4 | $97K | Buy |
65,966
+7,598
| +13% | +$11.2K | 0.02% | 1129 |
|
|
2023
Q3 | $70.6K | Sell |
58,368
-48,016
| -45% | -$58.1K | 0.01% | 1230 |
|
|
2023
Q2 | $154K | Sell |
106,384
-13,477
| -11% | -$19.5K | 0.03% | 1086 |
|
|
2023
Q1 | $174K | Sell |
119,861
-226,873
| -65% | -$329K | 0.04% | 994 |
|
|
2022
Q4 | $600K | Buy |
+346,734
| New | +$600K | 0.13% | 223 |
|
|
2022
Q2 | – | Sell |
-13,260
| Closed | -$115K | – | 1088 |
|
|
2022
Q1 | $115K | Buy |
+13,260
| New | +$115K | 0.05% | 494 |
|